Capital Performance Advisors’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.45M Sell
7,956
-3,904
-33% -$1.19M 0.22% 50
2026
Q1
$2.53M Buy
11,860
+301
+3% +$67.3K 0.17% 61
2025
Q4
$1.98M Buy
11,559
+564
+5% +$87.7K 0.14% 72
2025
Q3
$1.47M Buy
10,995
+369
+3% +$39.1K 0.24% 52
2025
Q2
$1.03M Buy
10,626
+2,552
+32% +$202K 0.2% 61
2025
Q1
$587K Buy
8,074
+1,857
+30% +$146K 0.13% 84
2024
Q4
$449K Sell
6,217
-403
-6% -$30.6K 0.14% 63
2024
Q3
$540K Buy
6,620
+200
+3% +$17.4K 0.16% 47
2024
Q2
$684K Buy
6,420
+240
+4% +$23K 0.26% 40
2024
Q1
$601K Buy
6,180
+50
+0.8% +$4.4K 0.23% 44
2023
Q4
$480K Buy
6,130
+130
+2% +$8.86K 0.21% 38
2023
Q3
$376K Sell
6,000
-70
-1% -$4.6K 0.19% 39
2023
Q2
$390K Buy
6,070
+70
+1% +$3.95K 0.19% 36
2023
Q1
$318K Hold
6,000
0.17% 37
2022
Q4
$252K Hold
6,000
0.14% 38
2022
Q3
$220K Hold
6,000
0.14% 37
2022
Q2
$256K Hold
6,000
0.16% 36
2022
Q1
$323K Hold
6,000
0.18% 34
2021
Q4
$333K Buy
+6,000
New +$376K 0.2% 30

Other funds holding LRCX

Capital Performance Advisors's LRCX Position: Q2 2026 in Review

Capital Performance Advisors reduced its Lam Research (LRCX) stake by 33% in Q2 2026, selling an estimated $1.19M and leaving 7,956 shares worth $3.45M. The position accounts for 0.22% of the portfolio, ranked #50.

Capital Performance Advisors first reported a position in LRCX in Q4 2021 and has held it in 19 quarters since. 3,114 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • Capital Performance Advisors held 7,956 shares of Lam Research worth $3.45M as of Q2 2026.
  • Capital Performance Advisors sold 3,904 Lam Research shares in Q2 2026, an estimated $1.19M.
  • Lam Research made up 0.22% of Capital Performance Advisors's portfolio in Q2 2026, its #50 holding.
  • Capital Performance Advisors first reported a position in Lam Research in Q4 2021 and has held it in 19 quarters since.
  • 3,114 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Capital Performance Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.